Shares of Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY – Get Free Report) gapped up prior to trading on Wednesday. The stock had previously closed at $10.23, but opened at $10.59. Santen Pharmaceutical shares last traded at $10.59, with a volume of 138 shares.
Santen Pharmaceutical Price Performance
The stock’s 50-day moving average is $11.53 and its 200-day moving average is $11.74.
Santen Pharmaceutical Company Profile
Santen Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company focused on ophthalmology. The company researches, develops, manufactures and markets prescription ophthalmic medicines and related products used to treat eye diseases and disorders.
Its product portfolio addresses conditions including glaucoma, dry eye disease, retinal diseases, ocular allergies, infections and inflammation. Santen also develops treatments for other serious vision-related conditions and provides products for eye-care professionals and patients.
Founded in 1890 and headquartered in Osaka, Japan, Santen has built a business serving patients and healthcare providers in Japan and international markets, including other parts of Asia, Europe and North America.
Featured Stories
- Five stocks we like better than Santen Pharmaceutical
- Morgan Stanley Is Bullish on Apple—But With a Catch
- Disney Is Opening the Door to Netflix—and Changing the Streaming Playbook
- DraftKings Stacks the Deck: The $800M Prediction Pivot
- Wall Street Is Betting These 3 Beaten-Down Stocks Have More Room to Run
Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
